Recent analysis of a larger series confirmed SMARCB1 as the primary tumor suppressor gene involved in the development of rhabdoid tumors with no recurrent additional oncogenic canonical pathway mutations identified13. Here, SMARCB1 is linked to rhabdoid tumor.